vs
Pediatrix Medical Group, Inc.（MD）与奇富科技（QFIN）财务数据对比。点击上方公司名可切换其他公司
奇富科技的季度营收约是Pediatrix Medical Group, Inc.的1.5倍（$731.2M vs $493.8M），奇富科技净利率更高（27.5% vs 6.8%，领先20.7%），过去两年奇富科技的营收复合增速更高（16.4% vs -0.1%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
奇富科技（原360数科）是中国头部金融科技企业，主要为持牌金融机构提供智能风控、信贷技术解决方案，服务广大个人消费者及中小微企业，依托大数据、人工智能技术提升金融服务的普惠性与运营效率。
MD vs QFIN — 直观对比
营收规模更大
QFIN
是对方的1.5倍
$493.8M
净利率更高
QFIN
高出20.7%
6.8%
两年增速更快
QFIN
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $731.2M |
| 净利润 | $33.7M | $201.2M |
| 毛利率 | — | — |
| 营业利润率 | 9.9% | 32.7% |
| 净利率 | 6.8% | 27.5% |
| 营收同比 | -1.7% | — |
| 净利润同比 | 10.5% | — |
| 每股收益（稀释后） | $0.40 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDQFIN
| Q4 25 | $493.8M | — | ||
| Q3 25 | $492.9M | $731.2M | ||
| Q2 25 | $468.8M | $728.1M | ||
| Q1 25 | $458.4M | $646.4M | ||
| Q4 24 | $502.4M | — | ||
| Q3 24 | $511.2M | $622.7M | ||
| Q2 24 | $504.3M | $572.4M | ||
| Q1 24 | $495.1M | $575.2M |
净利润MDQFIN
| Q4 25 | $33.7M | — | ||
| Q3 25 | $71.7M | $201.2M | ||
| Q2 25 | $39.3M | $241.6M | ||
| Q1 25 | $20.7M | $247.6M | ||
| Q4 24 | $30.5M | — | ||
| Q3 24 | $19.4M | $256.3M | ||
| Q2 24 | $-153.0M | $189.4M | ||
| Q1 24 | $4.0M | $160.7M |
营业利润率MDQFIN
| Q4 25 | 9.9% | — | ||
| Q3 25 | 13.8% | 32.7% | ||
| Q2 25 | 12.8% | 41.0% | ||
| Q1 25 | 7.0% | 42.1% | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 6.6% | 52.4% | ||
| Q2 24 | -31.3% | 47.7% | ||
| Q1 24 | 3.2% | 32.8% |
净利率MDQFIN
| Q4 25 | 6.8% | — | ||
| Q3 25 | 14.5% | 27.5% | ||
| Q2 25 | 8.4% | 33.2% | ||
| Q1 25 | 4.5% | 38.3% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 3.8% | 41.2% | ||
| Q2 24 | -30.3% | 33.1% | ||
| Q1 24 | 0.8% | 27.9% |
每股收益（稀释后）MDQFIN
| Q4 25 | $0.40 | — | ||
| Q3 25 | $0.84 | — | ||
| Q2 25 | $0.46 | — | ||
| Q1 25 | $0.24 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.23 | — | ||
| Q2 24 | $-1.84 | — | ||
| Q1 24 | $0.05 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | $6.5B |
| 总债务越低越好 | $570.5M | — |
| 股东权益账面价值 | $865.9M | $24.3B |
| 总资产 | $2.2B | $61.4B |
| 负债/权益比越低杠杆越低 | 0.66× | — |
8季度趋势，按日历期对齐
现金及短期投资MDQFIN
| Q4 25 | $375.2M | — | ||
| Q3 25 | $340.1M | $6.5B | ||
| Q2 25 | $224.7M | $5.3B | ||
| Q1 25 | $99.0M | $8.6B | ||
| Q4 24 | $229.9M | — | ||
| Q3 24 | $103.8M | $4.3B | ||
| Q2 24 | $19.4M | $6.3B | ||
| Q1 24 | $8.0M | $5.3B |
总债务MDQFIN
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MDQFIN
| Q4 25 | $865.9M | — | ||
| Q3 25 | $890.7M | $24.3B | ||
| Q2 25 | $833.8M | $24.1B | ||
| Q1 25 | $789.2M | $23.1B | ||
| Q4 24 | $764.9M | — | ||
| Q3 24 | $732.5M | $22.9B | ||
| Q2 24 | $706.5M | $22.6B | ||
| Q1 24 | $856.2M | $22.1B |
总资产MDQFIN
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $61.4B | ||
| Q2 25 | $2.1B | $59.8B | ||
| Q1 25 | $2.0B | $55.6B | ||
| Q4 24 | $2.2B | — | ||
| Q3 24 | $2.1B | $47.0B | ||
| Q2 24 | $2.0B | $47.0B | ||
| Q1 24 | $2.2B | $47.4B |
负债/权益比MDQFIN
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | $351.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 3.39× | 1.75× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDQFIN
| Q4 25 | $114.1M | — | ||
| Q3 25 | $137.3M | $351.4M | ||
| Q2 25 | $137.2M | $366.0M | ||
| Q1 25 | $-117.5M | $386.6M | ||
| Q4 24 | $133.0M | — | ||
| Q3 24 | $91.8M | $338.0M | ||
| Q2 24 | $107.0M | $269.9M | ||
| Q1 24 | $-125.2M | $271.2M |
现金转化率MDQFIN
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | 1.75× | ||
| Q2 25 | 3.49× | 1.52× | ||
| Q1 25 | -5.66× | 1.56× | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | 1.32× | ||
| Q2 24 | — | 1.43× | ||
| Q1 24 | -31.03× | 1.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
QFIN
暂无分部数据
